InvestorsHub Logo

rechnerhand

10/05/15 5:01 AM

#454 RE: BiotechValues #453

Hello Mr. Anderson,

It's obvious that this company is in trouble at the moment (annual report end of May 2015). Why is there no critical comment on your webpage which refers to GGG.v financial situation?

There are a few companies they put their results online ... look at Lomiko by the way.
http://www.lomiko.com/investors/reports.html

I didn't checked all of your named companies but here is 3D systems one.
http://www.3dsystems.com/investor/annual-reports

And no - it doesn't help if someone like you just post something positive without giving a complete perspective.

GGG.v may just gained something about Mio.1$ after that annual season but the main thing is that revenues by selling filaments seem to be more underachieve.
Revenue: $41.000
Start of sale: March, 16th
Price per filament box: $55

They sold (best case) 745 boxes and they have a negative costs of goods sold and under the line an operations net loss of Mio.4,2$ ... Something is not working that proper.
I'm really disappointed and honestly missing a statement by MM to that last (first) year. What about the strategy to increase revenues along with decrease costs of goods sold?